or Try an Advanced Search...

    Severe Plaque Psoriasis Stocks List

    Symbol Grade Name % Change
    BIIB F Biogen Idec Inc. -0.07
    ABBV D AbbVie Inc. 3.04
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major
    Related Stock Lists: Immunosuppressants Psoriasis S&P 500 Adalimumab Advanced Prostate Cancer Alzheimer's Disease Anemia Atopic Dermatitis Autoimmune Disease Autoimmune Disorders Biotechnology Blood Cancers Cd20 Chronic Idiopathic Constipation Chronic Lymphocytic Leukemia Clinical Trial Product Clinical Trial Products Combination Drugs Constipation Crohn's Disease

    Related ETFs - A few ETFs which own one or more of the above listed Severe Plaque Psoriasis stocks.

    Symbol Grade Name Weight
    MEDX F Horizon Kinetics Medical ETF 10.89
    HDLB B ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 9.62
    BOTZ B Global X Robotics & Artificial Intelligence Thematic ETF 9.31
    GRID C First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund 7.75
    View all Severe Plaque Psoriasis ETFs...
    Compare ETFs
    Compare HDLB to BOTZ Compare HDLB to FTXH Compare HDLB to GRID

        Severe Plaque Psoriasis Stocks Recent News

        Date Stock Title
        Nov 22 ABBV AbbVie gains on Leerink Partners upgrade to Outperform
        Nov 22 ABBV AbbVie: Upgrading To 'Strong Buy' After Pullback
        Nov 22 ABBV J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
        Nov 22 ABBV AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
        Nov 22 ABBV AbbVie upgraded to outperform by Leerink on recent sell-off
        Nov 22 BIIB Goldman Sachs: Biogen Inc. (BIIB) Is A Top Growth Investor Stock
        Nov 22 BIIB Biogen price target lowered to $207 from $251 at Mizuho
        Nov 20 BIIB Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
        Nov 20 ABBV Unpacking the Latest Options Trading Trends in AbbVie
        Nov 20 BIIB Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 BIIB Biogen, UCB release phase 3 data on lupus candidate dapirolizumab
        Nov 19 ABBV ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
        Nov 19 ABBV Where Will AbbVie Be in 5 Years?
        Nov 19 ABBV RVPH: Year-End OLE Update
        Nov 19 ABBV What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
        Nov 19 BIIB Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
        Nov 18 ABBV AbbVie snaps eight straight sessions of losses
        Nov 18 BIIB Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
        Nov 18 ABBV Aldeyra announces FDA acceptance of resubmitted reproxalap application
        Nov 18 BIIB Needham downgrades Biogen on slow growth of Alzheimer's drug
        Related Industries: Drug Manufacturers - Major
        Related Stock Lists: Immunosuppressants Psoriasis S&P 500 Adalimumab Advanced Prostate Cancer Alzheimer's Disease Anemia Atopic Dermatitis Autoimmune Disease Autoimmune Disorders Biotechnology Blood Cancers Cd20 Chronic Idiopathic Constipation Chronic Lymphocytic Leukemia Clinical Trial Product Clinical Trial Products Combination Drugs Constipation Crohn's Disease
        Severe Plaque Psoriasis

        Browse All Tags